Sort
50,496 grants matching “lung cancer”
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
$443,669Kwon-Sik Park · University Of Virginia · R01 · FY2015 · CA
Proteomics Biomarkers Development Laboratory
$443,657Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2009 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$443,656Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Cancer in adults following in utero and early life exposure to arsenic
$443,622Craig M Steinmaus · University Of California Berkeley · R01 · FY2016 · ES
Role of Formylpeptide Receptors in Host Defense
$443,620Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Integrated Chemoselective and Informatic Platform for Large-Scale Metabolomics
$443,605Teresa W-M Fan · University Of Kentucky · R01 · FY2014 · ES
3-Methylindole-Induced Lung Injury
$443,600Garold S Yost · University Of Utah · R01 · FY2008 · HL
Novel L-threo-sphinganines for ceramides-based cancer therapy
$443,579Barry J Maurer · Texas Tech University Health Scis Center · R15 · FY2012 · CA
IMRT in the Treatment of Node-Positive Breast Cancer
$443,551Lori J Pierce · University Of Michigan At Ann Arbor · R01 · FY2006 · CA
Assessment of consumer response to smokeless tobacco modified risk marketing orders
$443,509Richard J O'Connor · Roswell Park Cancer Institute Corp · R21 · FY2024 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$443,412Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Histone Deacetylation Signaling in Aging and Cancer Pathways
$443,383Katrin F Chua · Palo Alto Veterans Instit For Research · R01 · FY2023 · CA
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$443,381A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$443,291Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2022 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2023 · CA
A Pathway of Tumor Suppression
$443,233Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
A Role for KSHV in the Pathogenesis of Malignancies
$443,193Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
The Role of Schwann Cells in the Progression of Melanoma
$443,178Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Protein Biomarkers of Cancer Risk in Older Persons
$443,168Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Multiscale Nanotechnologies for Comprehensive Assessment of Lung Cancer in Blood
$443,156Shan X. Wang · Stanford University · U54 · FY2019 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$443,145Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Impact of pathogenic missense mutations on the ARID domain of ARID1a
$443,128Hugo Sanabria · Clemson University · R15 · FY2023 · CA
The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer
$443,127Jane Y Wu · Northwestern University At Chicago · R01 · FY2015 · CA
LACE-Bio-II: Identification, validation and implementation of prognostic and/or p
$443,119Lesley Katie Seymour · Queen'S University At Kingston · R01 · FY2012 · CA